Folic Acid [orch, phsu, vita]
Fenofibrate [orch, phsu]
Induced [ftcn]
Elevation [topp]
homocysteine [aapp, bacs]
Cysteine [aapp, bacs]
Elevated [qlco]
Plasma homocysteine level [lbpr]
considered [idcn]
Independent [idcn]
Atherosclerosis [dsyn]
Reported [inpr]
Lipid-lowering therapy [topp]
Fibric Acid Derivatives [orch]
Fibrates [orch, phsu]
Plasma [bdsu]
homocysteine [aapp, bacs]
Plasma [bdsu]
Cysteine [aapp, bacs]
Levels [qlco]
Study [mnob]
therapy [ftcn]
Folic Acid [orch, phsu, vita]
Plasma [bdsu]
homocysteine [aapp, bacs]
lowering [spco]
Agent [chvf]
MODIFY [ftcn]
Fenofibrate [orch, phsu]
Induced [ftcn]
Elevation [topp]
Plasma [bdsu]
aminothiol [orch]
Methods [inpr]
Patients [podg]
Combined hyperlipidemia NOS [dsyn]
N NOS [aapp, imft]
randomized [resa]
Receive [qlco]
weeks [tmco]
treatment [ftcn]
Fenofibrate 200 MG [clnd]
f group [clas]
Fenofibrate 200 MG [clnd]
Folic Acid [orch, phsu, vita]
mg% [qnco]
f group [clas]
Plasma homocystine level [lbpr]
therapy [ftcn]
Chromatography, High Performance Liquid [lbpr]
Plasma homocysteine level [lbpr]
Increased [qnco]
f group [clas]
f group [clas]
Group P [inpr]
Plasma [bdsu]
Cysteine [aapp, bacs]
Increased [qnco]
Treatments [topp]
P NOS [aapp, imft]
Serum creatinine level [lbtr]
Increased [qnco]
f group [clas]
f group [clas]
P NOS [aapp, imft]
Plasma homocysteine level [lbpr]
f group [clas]
Correlated [qlco]
creatinine levels [lbtr]
R- [spco]
effects [qlco]
Lipid [lipd]
Profile [lbpr]
treatment [ftcn]
Group [idcn]
Conclusions [idcn]
Folic Acid [orch, phsu, vita]
Fenofibrate [orch, phsu]
Induced [ftcn]
Elevation [topp]
Plasma [bdsu]
homocysteine [aapp, bacs]
Creatinine [bacs, orch]
Affect [menp]
Elevation [topp]
Folic Acid [orch, phsu, vita]
Neutral [qlco]
Lipid [lipd]
Lower (action) [acty]
Fenofibrate [orch, phsu]
Efficacy [qlco]
Fenofibrate [orch, phsu]
Improved [qlco]
Folic Acid [orch, phsu, vita]
